date,title,source
Oct-23-18,Cramer's lightning round: If you want to invest in non-op...,CNBC Videos
Oct-31-18,Heron Announces FDA Submission of HTX-011 NDA for Postoperative Pain Management,PR Newswire
Nov-07-18,"Heron Therapeutics (HRTX) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-07-18,Heron Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-07-18,"Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Corporate Progress",PR Newswire
Nov-12-18,U.S. Surgeon General Jerome Adams Discusses Opioid Alternatives and the Importance of Partnerships at Heron Therapeutics,PR Newswire
Nov-12-18,Today's Research Reports on Trending Tickers: Heron Therapeutics and Bristol-Myers Squibb,ACCESSWIRE
Nov-20-18,Heron Therapeutics to Present at the Evercore ISI HealthCONx Conference,PR Newswire
Nov-21-18,When Will Heron Therapeutics Inc (NASDAQ:HRTX) Become Profitable?,Simply Wall St.
Nov-26-18,Today's Research Reports on Trending Tickers: Cronos Group and Heron Therapeutics,ACCESSWIRE
Nov-27-18,"Report: Exploring Fundamental Drivers Behind Aclaris Therapeutics, Extreme Networks, Care, Air Lease, Globus Medical, and Heron Therapeutics  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-29-18,Today's Research Reports on Trending Tickers: Heron Therapeutics and Supernus Pharmaceuticals,ACCESSWIRE
Dec-31-18,Heron Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,PR Newswire
Dec-31-18,Heron stock up 4.3% after opioid alternative granted priority review designation from FDA,MarketWatch
Dec-31-18,"FDA Grants Priority Review Designation for Heron Therapeutics' NDA for HTX-011, a Non-Opioid for Postoperative Pain Management",PR Newswire
Jan-02-19,"Company News For Jan 2, 2019",Zacks
Jan-02-19,Heron Gains on Priority Review Designation for Pain Drug,Zacks
Jan-03-19,90% of Patients Remain Opioid-Free When HTX-011 Is Given with an Over-the-Counter Analgesic Regimen in New Multi-center Postoperative Pain Management Study,PR Newswire
Jan-07-19,Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises,PR Newswire
Jan-30-19,"New Research Coverage Highlights Heron Therapeutics, IDACORP, Star Bulk Carriers, AngioDynamics, Marinus Pharmaceuticals, and Advaxis  Consolidated Revenues, Company Growth, and Expectations for 2019",GlobeNewswire
Jan-31-19,Today's Research Reports on Trending Tickers: Mylan and Heron Therapeutics,ACCESSWIRE
Feb-05-19,Heron Therapeutics Announces Retirement of Robert Rosen as President,PR Newswire
Feb-06-19,"How Much Did Heron Therapeutics, Inc.s (NASDAQ:HRTX) CEO Pocket Last Year?",Simply Wall St.
Feb-20-19,Heron Therapeutics to Present at the 8th Annual Leerink Partners Global Healthcare Conference,PR Newswire
Feb-22-19,"Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates",Zacks
Feb-22-19,Heron Therapeutics: 4Q Earnings Snapshot,Associated Press
Feb-22-19,"Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Recent Corporate Progress",PR Newswire
Mar-04-19,Heron Therapeutics to Present at the 39th Annual Cowen Healthcare Conference,PR Newswire
Mar-05-19,"Report: Exploring Fundamental Drivers Behind Caesars Entertainment, Party City Holdco, Rowan Companies, TiVo, Heron Therapeutics, and Cimarex Energy  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Mar-11-19,77% of Patients Remain Opioid-Free When HTX-011 Is Given with an Over-the-Counter Analgesic Regimen in New Multi-center Postoperative Pain Management Study in Bunionectomy,PR Newswire
Apr-01-19,Heron Announces European Medicines Agency Validation of Marketing Authorisation Application for HTX-011 for Postoperative Pain Management,PR Newswire
Apr-02-19,"What Kind Of Share Price Volatility Should You Expect For Heron Therapeutics, Inc. (NASDAQ:HRTX)?",Simply Wall St.
Apr-02-19,4 Biotech Stocks With Major Catalysts in April,Motley Fool
Apr-03-19,3 Promising Small Biotech Stocks to Watch,TheStreet.com
Apr-29-19,Implied Volatility Surging for Heron Therapeutics (HRTX) Stock Options,Zacks
Apr-30-19,Heres What Hedge Funds Think About Heron Therapeutics Inc (HRTX),Insider Monkey
May-01-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Heron Therapeutics, Inc. - HRTX",PR Newswire
May-01-19,This Biotech Now Has 'Some Breathing Room' After FDA Rejects Its Rival,Investor's Business Daily
May-01-19,Why Heron Therapeutics and Pacira BioSciences Are Moving in Opposite Directions Today,Motley Fool
May-01-19,Heron Therapeutics News: HRTX Stock Tanks on FDA Rejection,InvestorPlace
May-01-19,Heron Therapeutics Falls 20% After FDA Rejects Pain Drug,Benzinga
May-01-19,Update: Heron Therapeutics stock down 31% after FDA says it can't approve pain drug without more info,MarketWatch
May-01-19,Heron Therapeutics Receives Complete Response Letter For HTX-011 For The Management Of Postoperative Pain,PR Newswire
May-02-19,"Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Heron Therapeutics, Inc. (HRTX)",GlobeNewswire
May-02-19,Heron Therapeutics (HRTX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release,Zacks
May-02-19,"Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Heron Therapeutics, Inc. (HRTX)",ACCESSWIRE
May-07-19,Why Heron Therapeutics Stock Broke Down in April,Motley Fool
May-08-19,"When Will Heron Therapeutics, Inc. (NASDAQ:HRTX) Breakeven?",Simply Wall St.
May-09-19,"Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates",Zacks
May-09-19,Heron Therapeutics: 1Q Earnings Snapshot,Associated Press
May-09-19,"Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Progress",PR Newswire
May-13-19,"Lifshitz & Miller LLP Announces Investigation of 3M Company, Aquantia Corporation, Chesapeake Lodging Trust, Fluor Corporation, Gardner Denver Holdings, Inc., Heron Therapeutics, Inc., Intermolecular, Inc. and Mellanox Technologies, Ltd.",PR Newswire
May-14-19,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Heron Therapeutics, Inc. - HRTX",GlobeNewswire
May-14-19,Heron Therapeutics Presents New Results from Real-world Study Showing 95% of Postoperative Patients Remain Opioid-Free when HTX-011 Is Given with an Over-the-Counter Analgesic Regimen,PR Newswire
May-20-19,3 Top Healthcare Stocks to Buy Right Now,Motley Fool
May-21-19,Heron Therapeutics Announces Publication of Results from Phase 3 EPOCH 1 Study of HTX-011 in Patients Undergoing Bunionectomy,PR Newswire
May-29-19,Heron Therapeutics to Present at Jefferies 2019 Healthcare Conference,PR Newswire
